Documente Academic
Documente Profesional
Documente Cultură
S0031-9406(16)00023-7
http://dx.doi.org/doi:10.1016/j.physio.2015.12.005
PHYST 889
To appear in:
Physiotherapy
Received date:
Accepted date:
19-3-2014
3-12-2015
Please cite this article as: Crisostomo RSS, Candeias MS, Armada-da-Silva PAS,
Venous flow during manual lymphatic drainage applied to different regions of the lower
extremity in people with and without chronic venous insufficiency: a cross-sectional
study, Physiotherapy (2016), http://dx.doi.org/10.1016/j.physio.2015.12.005
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
ip
t
an
us
cr
ed
Ac
ce
pt
Corresponding author. Address: Escola Superior de Sade Dr. Lopes Dias, Instituto Politcnico de
Castelo Branco, Avenida do Empresrio, Campus da Talagueira, 6000-767 Castelo Branco, Portugal.
Tel.: +351 272340560/+351 968584992; fax: +351 272 340 568.
E-mail address: crisostomo.rute@ipcb.pt (R.S. dos Santos Crisstomo).
Page 1 of 35
*Abstract
Abstract
Objectives To evaluate the effect of manual lymphatic drainage (MLD) on venous flow
when applied to the medial and lateral aspects of the thigh and leg in patients with
chronic venous insufficiency (CVI) and healthy subjects.
ip
t
cr
us
an
age 47 (SD 12) years] and 29 subjects did not have CVI [mean age 39 (14) years].
Intervention MLD was applied by a certificated physical therapist to the medial and
ed
ce
pt
Ac
P0.001; mean difference -1.69; 95% confidence interval (CI) -2.418 to -0.968] and
lateral [6.16 (SD 3.35) cm3/second; P0.001; mean difference -1.04; 95% CI -1.699 to 0.389] aspects of the thigh. Venous flow augmentation in the femoral vein and great
saphenous vein was higher when MLD was applied to the medial aspect of the thigh
(P<0.001), while MLD had a similar effect on venous blood flow regardless of whether
it was applied to the medial or the lateral aspect of the leg (P=0.731).
Page 2 of 35
Conclusions MLD increases blood flow in deep and superficial veins. MLD should be
applied along the route of the venous vessels for improved venous return.
Ac
ce
pt
ed
an
us
cr
ip
t
Venous insufficiency
Page 3 of 35
<A>Introduction
Manual lymphatic drainage (MLD) is used as a conservative treatment for
chronic venous insufficiency (CVI) [1]. When applied along the course of the great
ip
t
saphenous vein [2] and before surgery [3,4], MLD appears to improve venous
cr
us
distribution of the superficial lymphatic vessels and ganglions [7], and exerts mild
pressure (<40 mmHg) over the underlying soft tissues to stimulate lymph flow and re-
an
The real impact of MLD on venous blood flow is unclear, but it has been
suggested to be minor [8]. Improving venous return in patients with CVI is important in
ed
order to avoid peripheral venous hypertension and consequent luminal hypoxaemia and
vein wall distension, which, in turn, impair blood perfusion and cause endothelial
ce
pt
hypoxia, leukocyte invasion of the vessel wall, oedema [10] and ongoing damage of
skin and subcutaneous tissues (i.e. lipodermosclerosis and skin ulceration) [11].
Although scarce, data show that MLD enhances venous blood flow in distinct
Ac
deep and superficial veins of the lower extremities in healthy subjects and patients with
chronic venous disease [2]. These are important observations given that MLD can be
performed not only by therapists, but also by patients and caregivers, if offered proper
advice and training [12]. Therefore, MLD may be an interesting alternative for the
conservative treatment of CVI [1,2,4]. However, the precise mechanisms by which
MLD increases venous blood flow are not fully understood. Previous data suggest that
MLD increases venous blood flow in superficial and deep veins regardless of the exact
1
Page 4 of 35
technique that is employed [2]. However, in the lower extremities, deep and,
particularly, superficial veins have a distinct anatomical distribution that may constrain
the efficacy of MLD [2].
Therefore, the aim of this study was to compare the changes in venous blood
ip
t
flow in deep and superficial veins during the application of MLD to the medial and
cr
lateral aspects of the thigh and leg. Vascular (cross-sectional area) and haemodynamic
(flow velocity and flow volume) changes were assessed in participants with and without
us
CVI in deep (femoral and popliteal) and superficial (great saphenous and small
saphenous) veins. Based on the anatomy of the veins in the lower extremity, it was
an
hypothesised that venous blood flow enhancement would be greater when MLD was
applied to the medial aspect of the thigh and leg, as the major veins course along this
side. Despite the fact that the small saphenous vein runs posteriorly and laterally across
ed
the leg [13], and the popliteal vein is deeply and centrally placed within the posterior
muscle compartment of the leg [14], higher augmentation of venous flow was expected
ce
pt
when MLD was applied to the medial aspect of the leg as this is the path followed by
the great saphenous vein.
Ac
MLD would be greater in subjects with CVI due to greater venous pooling in the leg.
2
Page 5 of 35
women and 12 men). Participants with CVI were recruited from the outpatient clinic of
a health school.
The demographic and clinical data of the participants are presented in Table 1.
All participants with CVI had venous blood reflux and Clinical-Etiological-Anatomical-
ip
t
cr
informed about the purpose and procedures of the study, and signed an informed
consent form. The study received ethical approval from the review board of the
us
an
ed
ce
pt
systemic or limb infection, recent musculoskeletal injury in the lower extremity, and
peripheral neuropathy in the lower extremity. In total, 21 subjects were excluded: 11
had a clinical CEAP classification below C3 (only had varicose veins, talangiectasias or
Ac
reticular veins), two had active ulcers (C6), three suffered from cardiac insufficiency,
three had arterial insufficiency, and two were over 65 years of age. In six participants
with CVI, data were not collected from the great saphenous vein due to previous
surgical treatment. For the same reason, the small saphenous vein was also excluded
from data collection in five of the participants with CVI.
<B>Clinical evaluations
3
Page 6 of 35
Venous duplex scanning (ESAOTE mylab 30cv, with 7-mm linear array
transducer scanned at 6 to 12 MHz) was undertaken with participants in a standing
position in order to confirm the diagnosis of CVI and to determine the exact anatomical
location (anatomical CEAP classification) of venous reflux (superficial, perforating
ip
t
and/or deep vein system) [15]. Clinical history, symptoms (fatigue, heavy sensation,
cr
itching, cramps and skin irritation) and severity of disease, according to CEAP clinical
class and venous clinical severity scores, were obtained following established guidelines
us
[15].
The CEAP classification considers: (1) clinical manifestations of the disease (C);
an
(2) aetiological factors (E), separated in congenital, primary and secondary (e.g. post-
thrombotic); (3) anatomical distribution of the disease (A), which can affect superficial,
perforator or deep veins; and (4) underlying pathophysiological findings (P), such as
ed
reflux, obstruction or both reflux and obstruction. According to the CEAP classification,
there are six chronic venous disease categories that range from C0 to C6. C0 represents
ce
pt
those individuals with objective evidence of venous disease (i.e. E, A and/or P), but
with no clinical manifestations. Class C1 is characterised by the presence of
telangiectasia or reticular veins. In Class C2, varicose veins are present. In Class C3,
Ac
oedema of venous aetiology is present. In Class C4, there are skin trophic changes (e.g.
C4a, pigmentation and/or eczema; C4b, lipodermatosclerosis and/or white atrophy).
Classes C5 and C6 are associated with the occurrence of venous ulcers; C5 corresponds
to cases of prior ulceration that healed, and C6 corresponds to cases with active venous
ulcers [16].
The venous clinical severity score quantifies 10 items using the range: 0 (none),
1 (mild), 2 (moderate) and 3 (severe), with a total range score of 0 to 30 (best to worst)
4
Page 7 of 35
[17]. The items are: pain or discomfort; varicose veins; venous oedema; skin
pigmentation; inflammation; induration; number of active ulcers; duration of active
ulcers; size of active ulcers; and use of compression therapy.
The anatomical location of venous reflux and other clinical features of the CVI
ip
t
group are presented in Table 1. The non-CVI participants were also evaluated to
cr
us
used the same ultrasound equipment. The leg with more complaints and worse clinical
signs was used to test the effects of MLD. In the non-CVI group, MLD techniques were
an
ed
Four veins were assessed via venous duplex ultrasound using an assessment
protocol adapted from a previous study [2]. The great saphenous vein was insonated
ce
pt
immediately below the confluence of the superficial inguinal veins, whereas the small
saphenous vein was insonated immediately below the saphenopopliteal junction. The
femoral vein was insonated below the confluence of the superficial inguinal veins, and
Ac
the popliteal vein was insonated just below the saphenopopliteal junction.
The veins were scanned in B-mode for 4 seconds to measure their cross-
sectional area, using tracings of the contour of the veins in the ultrasound scan. Peak
and mean venous flow velocity were measured throughout the 4-second interval using
the time integral calculation. Three measurements of cross-sectional area and blood
flow velocity were taken for all four veins, and the average was computed for analysis
(Fig. 1).
5
Page 8 of 35
Ultrasound measurements were taken at baseline (without MLD) and during the
ip
t
application of MLD [2] to the medial and lateral aspects of the thigh for the femoral
cr
vein and great saphenous vein, and during the application of MLD to the medial and
lateral aspects of the leg for the popliteal vein and small saphenous vein. Three separate
us
ultrasound measurements were taken sequentially for each condition, and the mean of
these measurements was used for further analysis. Participants were in a supine position
an
for the assessment of blood flow velocity in the femoral and great saphenous veins, and
in a prone position for assessment of the popliteal and small saphenous veins. The order
of blood flow measurements was randomised following a hierarchical procedure (see
ce
pt
ed
Fig. 2).
Ac
supine position. Blood flow volume was calculated based on cross-sectional area and
blood flow velocity as:
6
Page 9 of 35
ip
t
cr
The sonographer was blinded to the application of MLD using an opaque screen.
The MLD technique (call-up manoeuvre) was executed by a certificated physical
us
therapist (as expertise in MLD application may influence the results [18], the therapist
had more than 5 years of experience [19]) using two hands to apply an amount of
an
pressure just sufficient to stretch the skin. Stretching of the skin was maintained for at
least 4 seconds. The MLD technique (call-up manoeuvre) started and ended on the order
of the sonographer, and therefore synchronised with the ultrasound recording. With two
ed
hands joined together and palms facing the limb, the MLD stroke starts by using the
medial border of the hand placed proximally to the participants limb to pull the skin
ce
pt
and apply gentle pressure. Gradually, the two hands come into contact with the skin to
gently pull it proximally (Fig. 3).
Ac
<B>Statistical analysis
7
Page 10 of 35
All statistical tests were performed using Statistical Package for the Social
Sciences Version 17 (IBM Corp., Armonk, NY, USA). The normality of distribution
was tested using the ShapiroWilks test. A mixed-factorial analysis of variance with
three factors was used to test the effects of the dependent variables and interactions:
ip
t
group (two levels: CVI groups vs non-CVI group), place of MLD application (three
cr
levels: baseline vs medial aspect vs lateral aspect; or two levels: medial aspect vs lateral
aspect only) and type of vein (two levels: deep vein vs superficial vein). Statistical
us
analysis using this model was performed separately for the thigh and the leg.
Bonferronis correction was used to correct for multiple pairwise comparisons. The
an
relationship between the magnitude of the effect of the MLD technique, in terms of
percentage change from baseline, and severity of CVI, as given by the venous clinical
severity score classification, was calculated using Spearmans rank correlation
ed
ce
pt
Bland and Altman limits of agreement were also calculated. The significance level was
set at P<0.05.
Ac
<A>Results
The demographic and clinical data of the participants are presented in Table 1.
All participants with CVI had pathological venous blood reflux in the lower extremity
and had a CEAP classification of C35.
No differences in height, weight and body mass index were found between the
CVI and non-CVI group. Nevertheless, the CVI group was slightly older than the non-
8
Page 11 of 35
CVI group {mean age 47 [standard deviation (SD) 12] years vs 39 (SD 14) years,
P=0.029}.
ip
t
Compared with baseline, MLD applied to the medial aspect of the thigh, but not
the lateral aspect, increased the cross-sectional area of the femoral vein in both groups
cr
(mean difference -0.042 cm2; P=0.008; 95% CI -0.074 to -0.009 cm2). The cross-
us
sectional area of the great saphenous vein remained unchanged during application of
MLD to the thigh.
an
Venous blood peak velocity (P=0.034), mean velocity (P=0.028) and blood flow
volume (P<0.001) in the femoral and great saphenous veins increased significantly in
response to the application of MLD to the medial and lateral aspects of the thigh (power
ed
=1.0), with larger increases with medial application (P0.001 for all variables; Fig. 4);
greater increases were seen in the great saphenous vein compared with the femoral vein
ce
pt
(P<0.05).
Ac
area were found between the CVI group and the non-CVI group (see Table 2).
9
Page 12 of 35
The cross-sectional area of the popliteal vein, but not that of the small saphenous
vein, increased similarly (P<0.001) regardless of whether MLD was applied to the
medial (mean difference -0.032 cm2; P<0.001; 95% CI -0.044 to -0.019 cm2) or lateral
(mean difference -0.026 cm2; P<0.001; 95% CI -0.037 to -0.015 cm2) aspect of the leg
cr
ip
t
us
Application of MLD to the leg increased peak (P<0.001) and mean blood
an
velocity (P<0.001), and flow volume (P<0.001, power=1.000), with greater increases in
the popliteal vein than the small saphenous vein (P<0.001). However, percentage
changes in blood flow velocity and blood flow volume as a result of the application of
ed
MLD to the leg were similar in the two veins. The CVI group and non-CVI group
responded differently to the application of MLD to the leg, with the percentage increase
ce
pt
in mean blood flow being higher in the small saphenous vein in the CVI group, and
higher in the popliteal vein in the non-CVI group.
Ac
No correlations could be found between percentage increases in blood flow (i.e. peak
and mean flow velocity, and flow volume), cross-sectional area of veins and the severity
of CVI, with the correlation coefficients ranging between 0.203 and 0.249.
<B>Reproducibility
10
Page 13 of 35
ip
t
cr
us
<A>Discussion
This study found that MLD, which is based on manual stretching of the skin and
an
underlying soft tissues, increases venous blood flow in superficial and deep veins, and
this occurs to a similar extent in participants with and without CVI. The increase in
venous flow was higher when MLD was applied to the medial aspect of the thigh,
ed
corresponding to the root of the great saphenous vein, compared with when MLD was
applied to the lateral aspect of the thigh. However, MLD was found to increase venous
ce
pt
flow similarly when applied to either the lateral or the medial aspect of the leg.
This study found that MLD increases blood flow in both superficial and deep
veins, which is in agreement with previous observations [2]. Nevertheless, data
Ac
collected from patients with heart failure and lower limb oedema point to small or even
insignificant effects of MLD on venous haemodynamics [8]. However, MLD is
commonly prescribed as a treatment for patients with CVI, especially when the
lymphatic system is affected and oedema is present [20]. Before CVI surgery, MLD
also appears to play an important role in improving the reflux volume index, disease
severity, quality of life [5] and venous oedema [4]. A small number of MLD sessions
11
Page 14 of 35
(i.e.10 sessions) without any other conservative treatments seems to have a positive,
although short-term, effect on symptoms, disease severity and venous oedema [1].
This study demonstrated that MLD produces the largest improvements in venous
blood flow when applied to the medial aspect of the thigh. MLD was applied exactly
ip
t
along the course of the great saphenous vein [13] and over the medial compartment of
cr
the thigh, which is crossed by the femoral vein [14]. This finding supports the
assumption that MLD should be applied over the trajectory of the great saphenous vein
us
in patients with CVI [3,5]. In turn, MLD was found to increase blood flow in the
popliteal and small saphenous veins to a similar extent regardless of whether the
an
technique was performed over the medial or lateral aspect of the leg. Anatomically, the
small saphenous vein lies posterior and laterally in the leg [13], while the popliteal vein
is deeply and centrally placed within the posterior muscle compartment of the leg [14].
ed
Therefore, both the popliteal vein and the small saphenous vein are placed relatively
equidistant from the medial and lateral aspects of the leg where the MLD manoeuvres
ce
pt
were applied. Also, the smaller size of the leg, at least compared with that of the thigh,
makes it difficult to restrict the effect of the MLD technique to just one aspect. These
findings suggest that MLD must consider venous anatomy and venous blood flow
Ac
direction, just like lymphatic anatomy and lymph flow direction, particularly in larger
body segments such as the thigh [79].
Inflammation of the skin, which is associated with venous stasis and venous
12
Page 15 of 35
contributing to blood stasis and CVI disease complications. Also, some of the
symptoms reported by patients with CVI [15,25] are presumed to be associated with the
inflammatory process triggered by adhesion of leukocytes to the endothelium, which is
a secondary event of venous stasis and considered to be an important
ip
t
cr
supports the benefit of many conservative treatments for CVI, such as exercise [27,28],
intermittent pneumatic pressure [29], kinesio taping [30], electrical muscle and nerve
us
an
ed
increasing venous flow velocity in deep veins, pressure applied to the lower extremity,
within the range of 80 to 100 mmHg or higher, forces the collapse of superficial veins
ce
pt
[35]. In contrast, this study found that MLD increased the cross-sectional area of both
superficial and deep veins, most likely because the amount of pressure applied over the
skin and underlying tissues was adequate. In most cases during the application of MLD,
Ac
the enlargement of veins was accompanied by increased blood flow, and therefore
venous blood flow increased substantially.
During ankle movements, changes in flow velocity in the femoral vein represent
approximately 20% to 40% [36] of baseline. In the great saphenous vein, ankle
movement increased flow velocity to 34.0 to 46.7 cm/second in healthy participants,
and slightly less in patients with CVI (21.0 to 43.1cm/second) [37]. This change in
venous flow is very similar to the results of the present study during MLD.
13
Page 16 of 35
Conservative CVI treatments, such as active tip-toe movement [38] and calf muscle
electrical stimulation, increase venous flow in the popliteal vein [32]; other treatments,
such as compression stockings, do not have a clear effect on venous flow [39].
Compared with these procedures, which predominantly enhance venous blood flow in
ip
t
the deep veins, MLD is able to increase blood flow in both superficial and deep veins.
cr
Moreover, the increase in venous blood flow during tip-toe movements seems to be
lower in patients with CVI compared with healthy counterparts [38], whereas MLD
us
improves venous return by the same extent in healthy subjects and patients with CVI, as
shown in the present study.
an
This study had a few limitations. These include the unknown effects of
ed
may influence venous flow. To account for these limitations, the data were also
analysed in terms of percentage change. Also, the real long-term effects of MLD and
ce
pt
Ac
The increase in venous blood flow occurs to a similar extent in subjects with and
without CVI. However, the change in blood flow in the deep and superficial veins of the
thigh is significantly higher when MLD is applied to the medial aspect of the thigh,
compared with the lateral aspect of the thigh. In the leg, MLD shows equal efficacy in
increasing venous blood flow when applied to the medial or lateral aspect. Further
studies are needed to ascertain the long-term effects of MLD in the conservative
treatment of venous disease.
14
Page 17 of 35
Acknowledgements
The authors wish to thank Aida Paulino, Maria Conceio Branco and Manuel Machado
from Unidade Local de Sade de Castelo Branco for referring patients to this study. The
ip
t
authors also wish to thank Diana Arraia for her help in data collection, and Isabele
cr
us
Ethical approval: The study received ethical approval by the review board of the
Scientific Council of the Faculty of Human Kinetics, University of Lisbon (Ref. No.
an
Parecer 10/2013).
Funding: This work was partially supported by a PhD grant by the Portuguese
ed
ce
pt
<A>References
Ac
[1] Crisostomo RS, Costa DS, Martins Cde L, Fernandes TI, Armada-da-Silva PA.
Influence of manual lymphatic drainage on health-related quality of life and symptoms
of chronic venous insufficiency: a randomized controlled trial. Arch Phys Med Rehabil
2015;96:28391.
[2] Dos Santos Crisostomo RS, Candeias MS, Ribeiro AM, da Luz Belo Martins C,
Armada-da-Silva PA. Manual lymphatic drainage in chronic venous disease: a duplex
ultrasound study. Phlebology 2014;29:66776.
15
Page 18 of 35
[3] Felty CL, Rooke TW. Compression therapy for chronic venous insufficiency. Semin
Vasc Surg 2005;18:3640.
[4] Molski P, Kruczynski J, Molski A, Molski S. Manual lymphatic drainage improves
the quality of life in patients with chronic venous disease: a randomized controlled trial.
ip
t
cr
[5] Molski P, Ossowski R, Hagner W, Molski S. Patients with venous disease benefit
us
[6] Ezzo J, Manheimer E, McNeely ML, Howell DM, Weiss R, Johansson KI, et al.
Manual lymphatic drainage for lymphedema following breast cancer treatment.
an
ed
Cancer 2011;11:94.
ce
pt
Ac
16
Page 19 of 35
[12] Brown JC, Cheville AL, Tchou JC, Harris SR, Schmitz KH. Prescription and
adherence to lymphedema self-care modalities among women with breast cancer-related
lymphedema. Support Care Cancer 2014;22:13543.
[13] Meissner MH, Moneta G, Burnand K, Gloviczki P, Lohr JM, Lurie F, et al. The
ip
t
cr
24S.
us
[15] Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, et
an
al. The care of patients with varicose veins and associated chronic venous diseases:
clinical practice guidelines of the Society for Vascular Surgery and the American
Venous Forum. J Vasc Surg 2011;53(Suppl.):2S48S.
ed
ce
pt
[17] Vasquez MA, Rabe E, McLafferty RB, Shortell CK, Marston WA, Gillespie D, et
al. Revision of the venous clinical severity score: venous outcomes consensus
statement: special communication of the American Venous Forum Ad Hoc Outcomes
Ac
17
Page 20 of 35
lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial.
BMJ 2010;340:b5396.
[20] Raju S, Furrh JBt, Neglen P. Diagnosis and treatment of venous lymphedema. J
Vasc Surg 2012;55:1419.
ip
t
[21] Caggiati A, Rosi C, Casini A, Cirenza M, Petrozza V, Acconcia MC, et al. Skin
cr
iron deposition characterises lipodermatosclerosis and leg ulcer. Eur J Vasc Endovasc
Surg 2010;40:77782.
us
an
[23] Morton LM, Phillips TJ. Venous eczema and lipodermatosclerosis. Semin Cutan
ed
venous disorders and its relationship to the calf muscle pump. Vasa 2009;38:1716.
[25] Darvall KA, Bate GR, Adam DJ, Bradbury AW. Generic health-related quality of
ce
pt
life is significantly worse in varicose vein patients with lower limb symptoms
independent of CEAP clinical grade. Eur J Vasc Endovasc Surg 2012;44:3414.
[26] Boisseau MR. Leukocyte involvement in the signs and symptoms of chronic
Ac
18
Page 21 of 35
[29] Lurie F, Scott V, Yoon HC, Kistner RL. On the mechanism of action of pneumatic
compression devices: combined magnetic resonance imaging and duplex ultrasound
investigation. J Vasc Surg 2008;48:10006.
[30] Aguilar-Ferrandiz ME, Castro-Sanchez AM, Mataran-Penarrocha GA, Garcia-
ip
t
cr
bioelectrical activity of the gastrocnemius muscle, range of ankle motion, and quality of
life in postmenopausal women with chronic venous insufficiency: a randomized
us
[31] Clarke Moloney M, Lyons GM, Breen P, Burke PE, Grace PA. Haemodynamic
an
study examining the response of venous blood flow to electrical stimulation of the
gastrocnemius muscle in patients with chronic venous disease. Eur J Vasc Surg
2006;31:3005.
ed
ce
pt
2010;39:6425.
[33] Downie SP, Raynor SM, Firmin DN, Wood NB, Thom SA, Hughes AD, et al.
Effects of elastic compression stockings on wall shear stress in deep and superficial
Ac
19
Page 22 of 35
ip
t
[37] Sochart DH, Hardinge K. The relationship of foot and ankle movements to venous
cr
[38] Crisostomo RS, Candeias MS, Armada-da-Siva PA. The use of ultrasound in the
evaluation of the efficacy of calf muscle pump function in primary chronic venous
us
[39] Stein PD, Matta F, Yaekoub AY, Ahsan ST, Badshah A, Younas F, et al. Effect of
an
compression stockings on venous blood velocity and blood flow. Thromb Haemost
Ac
ce
pt
ed
2010;103:13844.
20
Page 23 of 35
Table 1
Demographic and clinical data
CVI group
Non-CVI group
P
28
29
Age (years)
47 (12)
39 (14)
0.029
Height (cm)
164 (10)
165 (10)
0.719
Weight (kg)
69 (14)
66 (14)
0.349
BMI (kg/m2)
26 (4)
7 (4)
ip
t
ed
(%)
Sex
Male
Comorbidities
ce
pt
Female
us
an
24 (4)
0.101
cr
21 (75)
17 (59)
7 (25)
12 (41)
6 (21)
1 (4)
3 (11)
0 (0)
1 (3)
Ac
of
deep
venous
21
Page 24 of 35
Arterial hypertension
0 (0)
4 (14)
2 (7)
4 (14)
1 (4)
C3
13 (46)
C4
11 (39)
C5
4 (14)
Cardiorespiratory
disease
us
CEAP class
6 (21)
Superficial
perforator
5 (18)
12 (43)
Superficial
ed
veins
deep
an
Anatomical reflux
Superficial veins
5 (18)
24 (86)
14 (50)
Heavy legs
21 (75)
Pain
19 (68)
Skin irritation
12 (43)
Itching
17 (61)
Symptoms
Fatigue
Ac
Cramps
ce
pt
perforator veins
cr
ip
t
(treated)
BMI, body mass index; CEAP, Clinical Etiological Anatomical Pathological; SD, standard deviation.
a
22
Page 25 of 35
ip
t
cr
us
Table 2
Venous blood flow during manual lymphatic drainage (MLD) application to the thigh
an
21.07
(10.70)
25.39
(15.14)a
22.81
(14.67)a,b
28
Lateral aspect
28
Baseline
Medial aspect
28 14.04 (8.60)
28
17.58
(12.53)a
28
15.70
(12.19)a,b
Lateral aspect
Flow volume
(cm3/second)
28
Medial aspect
Ac
c
Baseline
27 0.41 (0.14)
27 0.45 (0.17)a
28 0.46 (0.17)a
Baseline
Medial aspect
Lateral aspect
ep
te
Femoral vein
Cross-sectional area
(cm2)
MLD application to
the thigh
n
Variables
CVI group
Percentage change from
Mean (SD)
baseline
Mean (SD)
Baseline
Medial aspect
Lateral aspect
27 5.09 (2.91)
27 6.82 (3.69)a
28 6.09 (3.44)a,b
Non-CVI group
Percentage change from
Mean (SD)
baseline
Mean (SD)
11 (26)
12 (22)
29 0.43 (0.20)
29 0.48 (0.20)a
29 0.44 (0.18)
13 (26)
3 (16)
29 20.14 (8.11)
21 (30)
29 24.59 (8.03)a
29 (33)
9 (24)b
29
19 (26)b
25 (41)
29 13.02 (6.48)
29 15.86 (6.44)a
40 (41)
12 (31)b
29
23 (36)b
39 (54)
28 (47)b
29 5.28 (3.60)
29 7.22 (3.68)a
29 6.22 (3.31)a,b
23.19
(7.80)a,b
14.93
(5.63)a,b
46 (49)
26 (38)b
23
Page 26 of 35
ip
t
Lateral aspect
22
Baseline
22 13.41 (9.18)
cr
22
Medial aspect
22
Lateral aspect
22
19.19
(12.25)
28.82
(19.97)a
22.00
(14.70)a,b
20.31
(15.62)a
15.66
(11.01)a,b
Baseline
22 1.63 (1.96)
Medial aspect
22 2.41 (2.66)a
Lateral aspect
22 1.87 (2.28)a,b
CVI, chronic venous insufficiency; SD, standard deviation.
a
5 (25)
1 (21)
us
Medial aspect
an
22
Ac
c
Flow volume
(cm3/second)
Baseline
ep
te
22 0.11 (0.07)
22 0.11 (0.08)
22 0.10 (0.07)
Baseline
Medial aspect
Lateral aspect
29 0.09 (0.04)
29 0.10 (0.05)
29 0.10 (0.05)
29
20.71
(14.43)
32.81
(24.77)a
25.68
(19.78)a,b
61 (71)
29
19 (33)b
29
29
64 (79)
29
24 (38)b
29
72 (88)
26 (49)b
29 1.34 (1.56)
29 2.26 (2.47)a
29 1.72 (1.80)a,b
14.02
(11.60)
22.92
(21.00)a
18.07
(16.31)a,b
8 (25)
6 (22)
55 (45)
23 (40)b
59 (41)
25 (37)b
72 (60)
34 (52)b
Significantly different from MLD application to the medial aspect of the thigh (P<0.05).
24
Page 27 of 35
ip
t
cr
us
Table 3
Variables
Baseline
Peak flow velocity
(cm/second)
Medial aspect
Lateral aspect
Ac
c
Baseline
Medial aspect
Lateral aspect
Flow volume
(cm3/second)
28 0.21 (0.15)
28 0.27 (0.19)a
28 0.25 (0.17)a
ep
te
Baseline
Cross-sectional area (cm2) Medial aspect
Lateral aspect
Popliteal vein
CVI group
Percentage change from
Mean(SD)
baseline
Mean (SD)
MLD application
to leg
an
Venous blood flow during manual lymphatic drainage (MLD) application to the leg.
Baseline
Medial aspect
Lateral aspect
27 18.17 (8.53)
37.12
28
(20.38)a
33.90
28
(16.00)a
27 11.95 (6.28)
23.45
28
(14.21)a
21.43
28
(11.33)a
27 2.31 (2.74)
28 5.76 (5.64)a
28 4.99 (4.38)a
Non-CVI group
Percentage change from
n Mean (SD)
baseline
Mean (SD)
49 (80)
35 (68)
29 0.19 (0.12)
29 0.23 (0.15)a
29 0.23 (0.13)a
42 (99)
54 (118)
29 19.69 (9.78)
42.00
29
(20.48)a
42.78
29
(21.27)a
113 (86)
109 (101)
101 (72)
102 (95)
208 (231)
172 (173)
29 12.30 (7.89)
27.90
29
(16.73)a
28.07
29
(17.14)a
29 2.26 (2.16)
29 6.36 (5.41)a
29 6.88 (6.15)a
132 (113)
134 (106)
161 (145)
153 (119)
292 (433)
300 (406)
25
Page 28 of 35
ip
t
cr
29 0.05 (0.03)
29 0.06 (0.03)
29 0.06 (0.04)
14 (24)
13 (25)
29 11.86 (5.25)
14.59
29
(5.98)a
13.99
29
(7.82)a
23 10.10 (2.67)
Medial aspect
23 12.74 (4.66)a
37 (66)
Lateral aspect
23
Baseline
Medial aspect
Lateral aspect
23 5.95 (2.26)
23 7.88 (3.57)a
23 9.09 (8.06)a
14.31
(10.82)a
ep
te
14 (22)
9 (26)
Baseline
23 0.05 (0.03)
22 0.06 (0.04)
23 0.05 (0.03)
an
Baseline
Cross-sectional area (cm2) Medial aspect
Lateral aspect
us
23 0.30 (0.28)
22 0.46 (0.49)a
23 0.55 (0.95)a
18 (29)
51 (104)
49 (76)
29 7.20 (3.94)
29 9.28 (5.98)a
29 8.61 (5.76)a
27 (38)
20 (32)
38 (58)
57 (74)
29 0.40 (0.38)
29 0.55 (0.52)a
29 0.52 (0.52)a
42 (45)
38 (58)
Ac
c
Baseline
Flow volume (ml/second) Medial aspect
Lateral aspect
a
Significantly different from baseline (P<0.05).
32 (55)
21 (32)
26
Page 29 of 35
Table 4
Reproducibility of ultrasound measurements
ICC
95% CI
-15.94 to 2.91
-12.56 to 2.42
cr
Cross-sectional area
9
0.97
0.84 to 0.96
0.00
of vein (cm2)
Peak flow velocity
9
0.47
0.84 to 0.96
6.21
(cm/second)
Mean flow velocity
9
0.50
-0.13 to 0.89
-5.07
(cm/second)
Flow volume
9
0.90
0.58 to 0.98
-0.92
(cm3/second)
ICC, intraclass correlation coefficient; CI, confidence interval.
ip
t
ICC
us
-5.11 to 3.27
an
Ac
ce
pt
ed
Agreement: mean difference and respective Bland and Altman 95% limits of agreement.
27
Page 30 of 35
cr
us
ip
t
blood flow velocity (C: baseline; D: during MLD) in the popliteal vein.
Fig. 3. Femoral vein and great saphenous vein ultrasound data collection: (A) at
an
baseline, (BD) during manual lymphatic drainage (MLD) application to the medial
aspect of the thigh, and (EG) during MLD application to the lateral aspect of the thigh.
Popliteal and small saphenous vein ultrasound data collection: (H) at baseline, (IK)
ed
during MLD application to the medial aspect of the leg, and (LN) during MLD
ce
pt
Fig. 4. Change (%) in flow volume in (A) the femoral vein and (B) the great saphenous
vein during manual lymphatic drainage (MLD) application to the medial and lateral
Ac
aspects of the thigh, and in (C) the popliteal vein and (D) the small saphenous vein
during MLD application to the medial and lateral aspects of the leg.
28
Page 31 of 35
Ac
ce
pt
ed
an
us
cr
Figure 1
Page 32 of 35
Ac
ce
pt
ed
an
us
cr
Figure 2
Page 33 of 35
Ac
ce
pt
ed
an
us
cr
Figure 3
Page 34 of 35
Ac
ce
pt
ed
an
us
cr
Figure 4
Page 35 of 35